#FutureReadyHealthcare
Indegene
Search Icon
Indegene Identified as a Leader in ISG’s Provider Lens™ Evaluation for Life Sciences Digital Services in Commercial Operations - Digital Evolution (Service Providers) Quadrant 2025
Home
News Indegene Identified by ISG as a Leader in Commercial Operations

Indegene Identified as a Leader in ISG’s Provider Lens™ Evaluation for Life Sciences Digital Services in Commercial Operations - Digital Evolution (Service Providers) Quadrant 2025

30 Jun 2025

Princeton, US, June 30, 2025: Information Services Group (ISG), a leading global technology research and advisory firm, has identified Indegene as a Leader in its Provider Lens™ for Life Sciences Digital Services in Commercial Operations - Digital Evolution (Service Providers) Quadrant 2025.

Rohan Sinha, Principal Analyst for Healthcare and Life Sciences at ISG, noted, “Indegene is a key player in life sciences commercial operations. They effectively streamline content processes and integrate seamlessly with major industry platforms, ultimately boosting client responsiveness and effectiveness."

ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems and streamlined content creation processes for improved content efficiency, and faster and more accurate review automation.

"We remain focused on helping our clients modernize and transform their commercial operations using an AI-first, data-driven approach," said Vivek Ghai, EVP - Enterprise Commercial Solutions, Indegene. "This recognition reflects our commitment and deep capabilities to delivering purpose-built, insight-driven solutions that accelerate commercial outcomes, and help our clients be future-ready."

indegene_identified_as_leader_in_isg_provider_lens_life_sciences

ISG evaluated 32 service providers with strong capabilities in digitally transforming life sciences commercial operations, focusing on areas such as data analytics, customer engagement, and personalized medicine. Indegene is the only life sciences specialist named as a leader in the quadrant.

ISG emphasized the critical role of technology in commercial operations, particularly in the context of omnichannel engagement, regulatory compliance, and growing GenAI adoption.

To download the full report, click here.

About Indegene

Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It's what drives Indegene's team and their purpose to enable healthcare organizations to be future-ready. To learn more, please visit www.indegene.com

Latest

Powered by Onetrust